Suppr超能文献

通过互联网销售的美国和印度制造的阿育吠陀药品中的铅、汞和砷。

Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet.

作者信息

Saper Robert B, Phillips Russell S, Sehgal Anusha, Khouri Nadia, Davis Roger B, Paquin Janet, Thuppil Venkatesh, Kales Stefanos N

机构信息

Department of Family Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118-2317, USA.

出版信息

JAMA. 2008 Aug 27;300(8):915-23. doi: 10.1001/jama.300.8.915.

Abstract

CONTEXT

Lead, mercury, and arsenic have been detected in a substantial proportion of Indian-manufactured traditional Ayurvedic medicines. Metals may be present due to the practice of rasa shastra (combining herbs with metals, minerals, and gems). Whether toxic metals are present in both US- and Indian-manufactured Ayurvedic medicines is unknown.

OBJECTIVES

To determine the prevalence of Ayurvedic medicines available via the Internet containing detectable lead, mercury, or arsenic and to compare the prevalence of toxic metals in US- vs Indian-manufactured medicines and between rasa shastra and non-rasa shastra medicines.

DESIGN

A search using 5 Internet search engines and the search terms Ayurveda and Ayurvedic medicine identified 25 Web sites offering traditional Ayurvedic herbs, formulas, or ingredients commonly used in Ayurveda, indicated for oral use, and available for sale. From 673 identified products, 230 Ayurvedic medicines were randomly selected for purchase in August-October 2005. Country of manufacturer/Web site supplier, rasa shastra status, and claims of Good Manufacturing Practices were recorded. Metal concentrations were measured using x-ray fluorescence spectroscopy.

MAIN OUTCOME MEASURES

Prevalence of medicines with detectable toxic metals in the entire sample and stratified by country of manufacture and rasa shastra status.

RESULTS

One hundred ninety-three of the 230 requested medicines were received and analyzed. The prevalence of metal-containing products was 20.7% (95% confidence interval [CI], 15.2%-27.1%). The prevalence of metals in US-manufactured products was 21.7% (95% CI, 14.6%-30.4%) compared with 19.5% (95% CI, 11.3%-30.1%) in Indian products (P = .86). Rasa shastra compared with non-rasa shastra medicines had a greater prevalence of metals (40.6% vs 17.1%; P = .007) and higher median concentrations of lead (11.5 microg/g vs 7.0 microg/g; P = .03) and mercury (20,800 microg/g vs 34.5 microg/g; P = .04). Among the metal-containing products, 95% were sold by US Web sites and 75% claimed Good Manufacturing Practices. All metal-containing products exceeded 1 or more standards for acceptable daily intake of toxic metals.

CONCLUSION

One-fifth of both US-manufactured and Indian-manufactured Ayurvedic medicines purchased via the Internet contain detectable lead, mercury, or arsenic.

摘要

背景

在很大一部分印度制造的传统阿育吠陀药物中检测到了铅、汞和砷。由于采用了“rasa shastra”(将草药与金属、矿物质和宝石混合)的做法,这些金属可能会存在。美国和印度制造的阿育吠陀药物中是否都存在有毒金属尚不清楚。

目的

确定通过互联网可获得的含有可检测到的铅、汞或砷的阿育吠陀药物的流行情况,并比较美国和印度制造的药物以及“rasa shastra”药物和非“rasa shastra”药物中有毒金属的流行情况。

设计

使用5个互联网搜索引擎并搜索“阿育吠陀”和“阿育吠陀药物”,确定了25个提供传统阿育吠陀草药、配方或阿育吠陀中常用成分的网站,这些产品供口服使用且可供销售。从673种已识别的产品中,在2005年8月至10月随机选择了230种阿育吠陀药物进行购买。记录制造商/网站供应商所在国家、“rasa shastra”状态以及良好生产规范声明。使用X射线荧光光谱法测量金属浓度。

主要观察指标

整个样本中以及按制造国家和“rasa shastra”状态分层的含有可检测到的有毒金属的药物的流行情况。

结果

收到并分析了230种所订购药物中的193种。含金属产品的流行率为20.7%(95%置信区间[CI],15.2% - 27.1%)。美国制造产品中金属的流行率为21.7%(95%CI,14.6% - 30.4%),而印度产品中为19.5%(95%CI,11.3% - 30.1%)(P = 0.86)。与非“rasa shastra”药物相比,“rasa shastra”药物中金属的流行率更高(40.6%对17.1%;P = 0.007),铅的中位数浓度更高(11.5微克/克对7.0微克/克;P = 0.03),汞的中位数浓度更高(20800微克/克对34.5微克/克;P = 0.04)。在含金属产品中,95%由美国网站销售,75%声称有良好生产规范。所有含金属产品都超过了有毒金属可接受每日摄入量的1项或多项标准。

结论

通过互联网购买的美国制造和印度制造的阿育吠陀药物中,五分之一含有可检测到的铅、汞或砷。

相似文献

2
Heavy metal content of ayurvedic herbal medicine products.
JAMA. 2004 Dec 15;292(23):2868-73. doi: 10.1001/jama.292.23.2868.
3
Bioaccessibility of lead and arsenic in traditional Indian medicines.
Sci Total Environ. 2011 Oct 1;409(21):4545-52. doi: 10.1016/j.scitotenv.2011.07.059. Epub 2011 Aug 23.
4
Metal content in Ayurvedic medicines.
JAMA. 2009 Jan 21;301(3):271; author reply 272. doi: 10.1001/jama.2008.1005.
5
Toxic metals in ayurvedic preparations from a public health lead poisoning cluster investigation.
Int J Occup Environ Health. 2017 Jul;23(3):187-192. doi: 10.1080/10773525.2018.1447880. Epub 2018 Mar 12.
6
Health Remedies as a Source of Lead, Mercury, and Arsenic Exposure, New York City, 2010-2019.
Am J Public Health. 2022 Sep;112(S7):S730-S740. doi: 10.2105/AJPH.2022.306906.
7
Are Ayurvedic medications store house of heavy metals?
Toxicol Res (Camb). 2022 Jan 15;11(1):179-183. doi: 10.1093/toxres/tfab124. eCollection 2022 Feb.
8
Speciation and bioavailability of lead in complementary medicines.
Sci Total Environ. 2016 Jan 1;539:304-312. doi: 10.1016/j.scitotenv.2015.08.124. Epub 2015 Sep 11.
9
Monitoring of mercury, arsenic, and lead in traditional Asian herbal preparations on the Dutch market and estimation of associated risks.
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2010 Feb;27(2):190-205. doi: 10.1080/02652030903207235.
10
Characterization and Antimicrobial Property of Some Heavy Metals Containing Ayurvedic Drugs.
Adv Exp Med Biol. 2018;1052:75-81. doi: 10.1007/978-981-10-7572-8_7.

引用本文的文献

1
Mercury Toxicity Mimicking Pheochromocytoma.
JCEM Case Rep. 2025 Aug 1;3(9):luaf152. doi: 10.1210/jcemcr/luaf152. eCollection 2025 Sep.
2
A Diagnostic and Management Challenge in Severe Fatal Mercury Poisoning Secondary to Homeopathic Medications.
Cureus. 2025 Jun 22;17(6):e86514. doi: 10.7759/cureus.86514. eCollection 2025 Jun.
3
Integrative approaches in Alzheimer's disease: evaluating the potential of traditional, complementary, and integrative medicine (TCIM).
Front Pharmacol. 2025 Jun 30;16:1561702. doi: 10.3389/fphar.2025.1561702. eCollection 2025.
4
Ayurvedic Ingredients in Dermatology: A Call for Research.
J Cosmet Dermatol. 2025 Feb;24(2):e16673. doi: 10.1111/jocd.16673. Epub 2024 Nov 17.
5
An Interesting Case of Acquired Renal Fanconi Syndrome.
Cureus. 2024 Jul 23;16(7):e65208. doi: 10.7759/cureus.65208. eCollection 2024 Jul.
6
Case of lead poisoning secondary to intake of herbal medicine for diabetes mellitus in a tertiary care hospital in Kerala.
Endocrinol Diabetes Metab Case Rep. 2024 Jun 10;2024(2). doi: 10.1530/EDM-23-0066. Print 2024 Apr 1.
7
Ayurvedic Medicine: A Traditional Medical System and Its Heavy Metal Poisoning.
Chonnam Med J. 2024 May;60(2):97-104. doi: 10.4068/cmj.2024.60.2.97. Epub 2024 May 24.
10
Unmasking herbal medication-induced lead poisoning in a geriatric patient with gastrointestinal symptoms.
BMJ Case Rep. 2023 Dec 12;16(12):e258065. doi: 10.1136/bcr-2023-258065.

本文引用的文献

3
National Institutes of Health State-of-the-science conference statement: multivitamin/mineral supplements and chronic disease prevention.
Ann Intern Med. 2006 Sep 5;145(5):364-71. doi: 10.7326/0003-4819-145-5-200609050-00136. Epub 2006 Jul 31.
4
Evaluation of metal and microbial contamination in botanical supplements.
J Agric Food Chem. 2004 Dec 29;52(26):7822-7. doi: 10.1021/jf049150+.
5
Heavy metal content of ayurvedic herbal medicine products.
JAMA. 2004 Dec 15;292(23):2868-73. doi: 10.1001/jama.292.23.2868.
6
7
Internet marketing of herbal products.
JAMA. 2003 Sep 17;290(11):1505-9. doi: 10.1001/jama.290.11.1505.
9
Medicinal herbs: a potential source of toxic metal exposure for man and animals in India.
Arch Environ Health. 2002 May-Jun;57(3):229-31. doi: 10.1080/00039890209602941.
10
The use and safety of non-allopathic Indian medicines.
Drug Saf. 2002;25(14):1005-19. doi: 10.2165/00002018-200225140-00003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验